Parkinson'S Disease Treatment - Global Market Outlook (2017-2026)

Parkinson'S Disease Treatment - Global Market Outlook (2017-2026)

  • Published: March 2018
  • ID: SMRC17090

According to Stratistics MRC, the Global Parkinson'S Disease Treatment market is accounted for $4.08 billion in 2017 and is expected to reach $7.93 billion by 2026 growing at a CAGR of 7.7%. Growing geriatric population coupled with neurological disorders, increasing investments in research & development activities, and raising healthcare awareness are some of the factors propelling the market growth during the forecast period. However, availability of other treatments is hindering the market growth.

By therapeutic class, Carbidopa/Levodopa segment is prognosticated to witness strong growth rate over the forecast period due to its potentiality and large acceptance for the parkinson’s disease treatment. Besides, online pharmacies are projected to grow at a higher growth rate during the forecast period.

By region, Asia Pacific is expected to witness highest growth rate due to growing medical tourism trend and raising medical infrastructure. Europe is dominating the global market with highest market revenue during the forecast period. This dominance is driven by increasing geriatric population and raising expenses on healthcare.

Some of the key players in Parkinson’s disease Treatment market include GlaxoSmithKline Plc., Abbvie, Acadia, Boehringer Ingelheim, Daiichi Sankyo, Impax Laboratories, Inc., Lundbeck, Merck, Novartis, Salix Pharmaceuticals, Sun Pharma, Teva Pharmaceutical Industries Ltd., UCB, Valeant Pharmaceuticals, and Wockhardt Limited. 

Therapeutic Class:
• Monoamine oxidase B inhibitors (MAO-B inhibitors)
• Dopamine precursors
• Dopamine agonists (non-ergoline)
• Catechol-O-methyl transferase (COMT) inhibitors
• Carbidopa/Levodopa
• Other Therapeutic Classes

Medical Devices:
• Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices
• Deep Brain Stimulation (DBS) Devices

Patient Care Setting:
• Hospitals
• Clinics

Distribution Channel:
• Retail pharmacies
• Online pharmacies
• Hospital pharmacies
• Drug stores

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan       
    • China       
    • India       
    • Australia 
    • New Zealand     
    • South Korea      
    • Rest of Asia Pacific   
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary    
      
2 Preface    
 
 2.1 Abstract    
 2.2 Stake Holders   
 2.3 Research Scope   
 2.4 Research Methodology  
  2.4.1 Data Mining  
  2.4.2 Data Analysis  
  2.4.3 Data Validation  
  2.4.4 Research Approach  
 2.5 Research Sources   
  2.5.1 Primary Research Sources 
  2.5.2 Secondary Research Sources 
  2.5.3 Assumptions  
      
3 Market Trend Analysis   
 3.1 Introduction   
 3.2 Drivers    
 3.3 Restraints   
 3.4 Opportunities   
 3.5 Threats    
 3.6 Product Analysis   
 3.7 Emerging Markets   
 3.8 Futuristic Market Scenario  
      
4 Porters Five Force Analysis   
 4.1 Bargaining power of suppliers  
 4.2 Bargaining power of buyers  
 4.3 Threat of substitutes  
 4.4 Threat of new entrants  
 4.5 Competitive rivalry   
      
5 Global Parkinson'S Disease Treatment Market, By Therapeutic Class
 5.1 Introduction    
 5.2 Monoamine oxidase B inhibitors (MAO-B inhibitors)
  5.2.1 Rasagiline  
  5.2.2 Selegiline  
 5.3 Dopamine precursors  
  5.3.1 Primidone  
  5.3.2 Phenobarbital  
 5.4 Dopamine agonists (non-ergoline) 
  5.4.1 Ropinirole  
  5.4.2 Pramipexole  
  5.4.3 Others (apomorphine and rotigotine)
 5.5 Catechol-O-methyl transferase (COMT) inhibitors
  5.5.1 Tolcapone  
  5.5.2 Entacapone  
 5.6 Carbidopa/Levodopa  
 5.7 Other Therapeutic Classes  
  5.7.1 Amantadine and Anticholinergic
      
6 Global Parkinson'S Disease Treatment Market, By Medical Devices
 6.1 Introduction    
 6.2 Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices
 6.3 Deep Brain Stimulation (DBS) Devices 
      
7 Global Parkinson'S Disease Treatment Market, By Patient Care Setting
 7.1 Introduction    
 7.2 Hospitals    
 7.3 Clinics    
      
8 Global Parkinson'S Disease Treatment Market, By Distribution Channel
 8.1 Introduction    
 8.2 Retail pharmacies   
 8.3 Online pharmacies   
 8.4 Hospital pharmacies  
 8.5 Drug stores    
      
9 Global Parkinson'S Disease Treatment Market, By Geography
 9.1 Introduction   
 9.2 North America   
  9.2.1 US   
  9.2.2 Canada   
  9.2.3 Mexico   
 9.3 Europe    
  9.3.1 Germany   
  9.3.2 UK   
  9.3.3 Italy   
  9.3.4 France   
  9.3.5 Spain   
  9.3.6 Rest of Europe  
 9.4 Asia Pacific   
  9.4.1 Japan   
  9.4.2 China   
  9.4.3 India   
  9.4.4 Australia   
  9.4.5 New Zealand  
  9.4.6 South Korea  
  9.4.7 Rest of Asia Pacific  
 9.5 South America   
  9.5.1 Argentina  
  9.5.2 Brazil   
  9.5.3 Chile   
  9.5.4 Rest of South America 
 9.6 Middle East & Africa  
  9.6.1 Saudi Arabia  
  9.6.2 UAE   
  9.6.3 Qatar   
  9.6.4 South Africa  
  9.6.5 Rest of Middle East & Africa 
      
10 Key Developments    
 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
 10.2 Acquisitions & Mergers  
 10.3 New Product Launch  
 10.4 Expansions   
 10.5 Other Key Strategies  
      
11 Leading Companies     
 11.1 GlaxoSmithKline Plc.  
 11.2 Abbvie     
 11.3 Acadia     
 11.4 Boehringer Ingelheim   
 11.5 Daiichi Sankyo   
 11.6 Impax Laboratories, Inc.  
 11.7 Lundbeck    
 11.8 Merck     
 11.9 Novartis     
 11.10 Salix Pharmaceuticals  
 11.11 Sun Pharma    
 11.12 Teva Pharmaceutical Industries Ltd. 
 11.13 UCB    
 11.14 Valeant Pharmaceuticals   
 11.15 Wockhardt Limited 


List of Tables     
1 Global Parkinson'S Disease Treatment Market By Region, Market Forecast (2016-2026) (US $MN)
2 Global Parkinson'S Disease Treatment Market By Therapeutic Class, Market Forecast (2016-2026) (US $MN)
3 Global Parkinson'S Disease Treatment Market By Monoamine oxidase B inhibitors (MAO-B inhibitors), Market Forecast (2016-2026) (US $MN)
4 Global Parkinson'S Disease Treatment Market By Rasagiline, Market Forecast (2016-2026) (US $MN)
5 Global Parkinson'S Disease Treatment Market By Selegiline, Market Forecast (2016-2026) (US $MN)
6 Global Parkinson'S Disease Treatment Market By Dopamine precursors, Market Forecast (2016-2026) (US $MN)
7 Global Parkinson'S Disease Treatment Market By Primidone, Market Forecast (2016-2026) (US $MN)
8 Global Parkinson'S Disease Treatment Market By Phenobarbital, Market Forecast (2016-2026) (US $MN)
9 Global Parkinson'S Disease Treatment Market By Dopamine agonists (non-ergoline), Market Forecast (2016-2026) (US $MN)
10 Global Parkinson'S Disease Treatment Market By Ropinirole, Market Forecast (2016-2026) (US $MN)
11 Global Parkinson'S Disease Treatment Market By Pramipexole, Market Forecast (2016-2026) (US $MN)
12 Global Parkinson'S Disease Treatment Market By Others (apomorphine and rotigotine), Market Forecast (2016-2026) (US $MN)
13 Global Parkinson'S Disease Treatment Market By Catechol-O-methyl transferase (COMT) inhibitors, Market Forecast (2016-2026) (US $MN)
14 Global Parkinson'S Disease Treatment Market By Tolcapone, Market Forecast (2016-2026) (US $MN)
15 Global Parkinson'S Disease Treatment Market By Entacapone, Market Forecast (2016-2026) (US $MN)
16 Global Parkinson'S Disease Treatment Market By Carbidopa/Levodopa, Market Forecast (2016-2026) (US $MN)
17 Global Parkinson'S Disease Treatment Market By Other Therapeutic Classes, Market Forecast (2016-2026) (US $MN)
18 Global Parkinson'S Disease Treatment Market By Amantadine and Anticholinergic, Market Forecast (2016-2026) (US $MN)
19 Global Parkinson'S Disease Treatment Market By Medical Devices, Market Forecast (2016-2026) (US $MN)
20 Global Parkinson'S Disease Treatment Market By Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices, Market Forecast (2016-2026) (US $MN)
21 Global Parkinson'S Disease Treatment Market By Deep Brain Stimulation (DBS) Devices, Market Forecast (2016-2026) (US $MN)
22 Global Parkinson'S Disease Treatment Market By Patient Care Setting, Market Forecast (2016-2026) (US $MN)
23 Global Parkinson'S Disease Treatment Market By Hospitals, Market Forecast (2016-2026) (US $MN)
24 Global Parkinson'S Disease Treatment Market By Clinics, Market Forecast (2016-2026) (US $MN)
25 Global Parkinson'S Disease Treatment Market By Distribution Channel, Market Forecast (2016-2026) (US $MN)
26 Global Parkinson'S Disease Treatment Market By Retail pharmacies, Market Forecast (2016-2026) (US $MN)
27 Global Parkinson'S Disease Treatment Market By Online pharmacies, Market Forecast (2016-2026) (US $MN)
28 Global Parkinson'S Disease Treatment Market By Hospital pharmacies, Market Forecast (2016-2026) (US $MN)
29 Global Parkinson'S Disease Treatment Market By Drug stores, Market Forecast (2016-2026) (US $MN)
30 North America Parkinson'S Disease Treatment Market By Country, Market Forecast (2016-2026) (US $MN)
31 North America Parkinson'S Disease Treatment Market By Therapeutic Class, Market Forecast (2016-2026) (US $MN)
32 North America Parkinson'S Disease Treatment Market By Monoamine oxidase B inhibitors (MAO-B inhibitors), Market Forecast (2016-2026) (US $MN)
33 North America Parkinson'S Disease Treatment Market By Rasagiline, Market Forecast (2016-2026) (US $MN)
34 North America Parkinson'S Disease Treatment Market By Selegiline, Market Forecast (2016-2026) (US $MN)
35 North America Parkinson'S Disease Treatment Market By Dopamine precursors, Market Forecast (2016-2026) (US $MN)
36 North America Parkinson'S Disease Treatment Market By Primidone, Market Forecast (2016-2026) (US $MN)
37 North America Parkinson'S Disease Treatment Market By Phenobarbital, Market Forecast (2016-2026) (US $MN)
38 North America Parkinson'S Disease Treatment Market By Dopamine agonists (non-ergoline), Market Forecast (2016-2026) (US $MN)
39 North America Parkinson'S Disease Treatment Market By Ropinirole, Market Forecast (2016-2026) (US $MN)
40 North America Parkinson'S Disease Treatment Market By Pramipexole, Market Forecast (2016-2026) (US $MN)
41 North America Parkinson'S Disease Treatment Market By Others (apomorphine and rotigotine), Market Forecast (2016-2026) (US $MN)
42 North America Parkinson'S Disease Treatment Market By Catechol-O-methyl transferase (COMT) inhibitors, Market Forecast (2016-2026) (US $MN)
43 North America Parkinson'S Disease Treatment Market By Tolcapone, Market Forecast (2016-2026) (US $MN)
44 North America Parkinson'S Disease Treatment Market By Entacapone, Market Forecast (2016-2026) (US $MN)
45 North America Parkinson'S Disease Treatment Market By Carbidopa/Levodopa, Market Forecast (2016-2026) (US $MN)
46 North America Parkinson'S Disease Treatment Market By Other Therapeutic Classes, Market Forecast (2016-2026) (US $MN)
47 North America Parkinson'S Disease Treatment Market By Amantadine and Anticholinergic, Market Forecast (2016-2026) (US $MN)
48 North America Parkinson'S Disease Treatment Market By Medical Devices, Market Forecast (2016-2026) (US $MN)
49 North America Parkinson'S Disease Treatment Market By Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices, Market Forecast (2016-2026) (US $MN)
50 North America Parkinson'S Disease Treatment Market By Deep Brain Stimulation (DBS) Devices, Market Forecast (2016-2026) (US $MN)
51 North America Parkinson'S Disease Treatment Market By Patient Care Setting, Market Forecast (2016-2026) (US $MN)
52 North America Parkinson'S Disease Treatment Market By Hospitals, Market Forecast (2016-2026) (US $MN)
53 North America Parkinson'S Disease Treatment Market By Clinics, Market Forecast (2016-2026) (US $MN)
54 North America Parkinson'S Disease Treatment Market By Distribution Channel, Market Forecast (2016-2026) (US $MN)
55 North America Parkinson'S Disease Treatment Market By Retail pharmacies, Market Forecast (2016-2026) (US $MN)
56 North America Parkinson'S Disease Treatment Market By Online pharmacies, Market Forecast (2016-2026) (US $MN)
57 North America Parkinson'S Disease Treatment Market By Hospital pharmacies, Market Forecast (2016-2026) (US $MN)
58 North America Parkinson'S Disease Treatment Market By Drug stores, Market Forecast (2016-2026) (US $MN)
59 Europe Parkinson'S Disease Treatment Market By Country, Market Forecast (2016-2026) (US $MN)
60 Europe Parkinson'S Disease Treatment Market By Therapeutic Class, Market Forecast (2016-2026) (US $MN)
61 Europe Parkinson'S Disease Treatment Market By Monoamine oxidase B inhibitors (MAO-B inhibitors), Market Forecast (2016-2026) (US $MN)
62 Europe Parkinson'S Disease Treatment Market By Rasagiline, Market Forecast (2016-2026) (US $MN)
63 Europe Parkinson'S Disease Treatment Market By Selegiline, Market Forecast (2016-2026) (US $MN)
64 Europe Parkinson'S Disease Treatment Market By Dopamine precursors, Market Forecast (2016-2026) (US $MN)
65 Europe Parkinson'S Disease Treatment Market By Primidone, Market Forecast (2016-2026) (US $MN)
66 Europe Parkinson'S Disease Treatment Market By Phenobarbital, Market Forecast (2016-2026) (US $MN)
67 Europe Parkinson'S Disease Treatment Market By Dopamine agonists (non-ergoline), Market Forecast (2016-2026) (US $MN)
68 Europe Parkinson'S Disease Treatment Market By Ropinirole, Market Forecast (2016-2026) (US $MN)
69 Europe Parkinson'S Disease Treatment Market By Pramipexole, Market Forecast (2016-2026) (US $MN)
70 Europe Parkinson'S Disease Treatment Market By Others (apomorphine and rotigotine), Market Forecast (2016-2026) (US $MN)
71 Europe Parkinson'S Disease Treatment Market By Catechol-O-methyl transferase (COMT) inhibitors, Market Forecast (2016-2026) (US $MN)
72 Europe Parkinson'S Disease Treatment Market By Tolcapone, Market Forecast (2016-2026) (US $MN)
73 Europe Parkinson'S Disease Treatment Market By Entacapone, Market Forecast (2016-2026) (US $MN)
74 Europe Parkinson'S Disease Treatment Market By Carbidopa/Levodopa, Market Forecast (2016-2026) (US $MN)
75 Europe Parkinson'S Disease Treatment Market By Other Therapeutic Classes, Market Forecast (2016-2026) (US $MN)
76 Europe Parkinson'S Disease Treatment Market By Amantadine and Anticholinergic, Market Forecast (2016-2026) (US $MN)
77 Europe Parkinson'S Disease Treatment Market By Medical Devices, Market Forecast (2016-2026) (US $MN)
78 Europe Parkinson'S Disease Treatment Market By Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices, Market Forecast (2016-2026) (US $MN)
79 Europe Parkinson'S Disease Treatment Market By Deep Brain Stimulation (DBS) Devices, Market Forecast (2016-2026) (US $MN)
80 Europe Parkinson'S Disease Treatment Market By Patient Care Setting, Market Forecast (2016-2026) (US $MN)
81 Europe Parkinson'S Disease Treatment Market By Hospitals, Market Forecast (2016-2026) (US $MN)
82 Europe Parkinson'S Disease Treatment Market By Clinics, Market Forecast (2016-2026) (US $MN)
83 Europe Parkinson'S Disease Treatment Market By Distribution Channel, Market Forecast (2016-2026) (US $MN)
84 Europe Parkinson'S Disease Treatment Market By Retail pharmacies, Market Forecast (2016-2026) (US $MN)
85 Europe Parkinson'S Disease Treatment Market By Online pharmacies, Market Forecast (2016-2026) (US $MN)
86 Europe Parkinson'S Disease Treatment Market By Hospital pharmacies, Market Forecast (2016-2026) (US $MN)
87 Europe Parkinson'S Disease Treatment Market By Drug stores, Market Forecast (2016-2026) (US $MN)
88 Asia Pacific Parkinson'S Disease Treatment Market By Country, Market Forecast (2016-2026) (US $MN)
89 Asia Pacific Parkinson'S Disease Treatment Market By Therapeutic Class, Market Forecast (2016-2026) (US $MN)
90 Asia Pacific Parkinson'S Disease Treatment Market By Monoamine oxidase B inhibitors (MAO-B inhibitors), Market Forecast (2016-2026) (US $MN)
91 Asia Pacific Parkinson'S Disease Treatment Market By Rasagiline, Market Forecast (2016-2026) (US $MN)
92 Asia Pacific Parkinson'S Disease Treatment Market By Selegiline, Market Forecast (2016-2026) (US $MN)
93 Asia Pacific Parkinson'S Disease Treatment Market By Dopamine precursors, Market Forecast (2016-2026) (US $MN)
94 Asia Pacific Parkinson'S Disease Treatment Market By Primidone, Market Forecast (2016-2026) (US $MN)
95 Asia Pacific Parkinson'S Disease Treatment Market By Phenobarbital, Market Forecast (2016-2026) (US $MN)
96 Asia Pacific Parkinson'S Disease Treatment Market By Dopamine agonists (non-ergoline), Market Forecast (2016-2026) (US $MN)
97 Asia Pacific Parkinson'S Disease Treatment Market By Ropinirole, Market Forecast (2016-2026) (US $MN)
98 Asia Pacific Parkinson'S Disease Treatment Market By Pramipexole, Market Forecast (2016-2026) (US $MN)
99 Asia Pacific Parkinson'S Disease Treatment Market By Others (apomorphine and rotigotine), Market Forecast (2016-2026) (US $MN)
100 Asia Pacific Parkinson'S Disease Treatment Market By Catechol-O-methyl transferase (COMT) inhibitors, Market Forecast (2016-2026) (US $MN)
101 Asia Pacific Parkinson'S Disease Treatment Market By Tolcapone, Market Forecast (2016-2026) (US $MN)
102 Asia Pacific Parkinson'S Disease Treatment Market By Entacapone, Market Forecast (2016-2026) (US $MN)
103 Asia Pacific Parkinson'S Disease Treatment Market By Carbidopa/Levodopa, Market Forecast (2016-2026) (US $MN)
104 Asia Pacific Parkinson'S Disease Treatment Market By Other Therapeutic Classes, Market Forecast (2016-2026) (US $MN)
105 Asia Pacific Parkinson'S Disease Treatment Market By Amantadine and Anticholinergic, Market Forecast (2016-2026) (US $MN)
106 Asia Pacific Parkinson'S Disease Treatment Market By Medical Devices, Market Forecast (2016-2026) (US $MN)
107 Asia Pacific Parkinson'S Disease Treatment Market By Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices, Market Forecast (2016-2026) (US $MN)
108 Asia Pacific Parkinson'S Disease Treatment Market By Deep Brain Stimulation (DBS) Devices, Market Forecast (2016-2026) (US $MN)
109 Asia Pacific Parkinson'S Disease Treatment Market By Patient Care Setting, Market Forecast (2016-2026) (US $MN)
110 Asia Pacific Parkinson'S Disease Treatment Market By Hospitals, Market Forecast (2016-2026) (US $MN)
111 Asia Pacific Parkinson'S Disease Treatment Market By Clinics, Market Forecast (2016-2026) (US $MN)
112 Asia Pacific Parkinson'S Disease Treatment Market By Distribution Channel, Market Forecast (2016-2026) (US $MN)
113 Asia Pacific Parkinson'S Disease Treatment Market By Retail pharmacies, Market Forecast (2016-2026) (US $MN)
114 Asia Pacific Parkinson'S Disease Treatment Market By Online pharmacies, Market Forecast (2016-2026) (US $MN)
115 Asia Pacific Parkinson'S Disease Treatment Market By Hospital pharmacies, Market Forecast (2016-2026) (US $MN)
116 Asia Pacific Parkinson'S Disease Treatment Market By Drug stores, Market Forecast (2016-2026) (US $MN)
117 South America Parkinson'S Disease Treatment Market By Country, Market Forecast (2016-2026) (US $MN)
118 South America Parkinson'S Disease Treatment Market By Therapeutic Class, Market Forecast (2016-2026) (US $MN)
119 South America Parkinson'S Disease Treatment Market By Monoamine oxidase B inhibitors (MAO-B inhibitors), Market Forecast (2016-2026) (US $MN)
120 South America Parkinson'S Disease Treatment Market By Rasagiline, Market Forecast (2016-2026) (US $MN)
121 South America Parkinson'S Disease Treatment Market By Selegiline, Market Forecast (2016-2026) (US $MN)
122 South America Parkinson'S Disease Treatment Market By Dopamine precursors, Market Forecast (2016-2026) (US $MN)
123 South America Parkinson'S Disease Treatment Market By Primidone, Market Forecast (2016-2026) (US $MN)
124 South America Parkinson'S Disease Treatment Market By Phenobarbital, Market Forecast (2016-2026) (US $MN)
125 South America Parkinson'S Disease Treatment Market By Dopamine agonists (non-ergoline), Market Forecast (2016-2026) (US $MN)
126 South America Parkinson'S Disease Treatment Market By Ropinirole, Market Forecast (2016-2026) (US $MN)
127 South America Parkinson'S Disease Treatment Market By Pramipexole, Market Forecast (2016-2026) (US $MN)
128 South America Parkinson'S Disease Treatment Market By Others (apomorphine and rotigotine), Market Forecast (2016-2026) (US $MN)
129 South America Parkinson'S Disease Treatment Market By Catechol-O-methyl transferase (COMT) inhibitors, Market Forecast (2016-2026) (US $MN)
130 South America Parkinson'S Disease Treatment Market By Tolcapone, Market Forecast (2016-2026) (US $MN)
131 South America Parkinson'S Disease Treatment Market By Entacapone, Market Forecast (2016-2026) (US $MN)
132 South America Parkinson'S Disease Treatment Market By Carbidopa/Levodopa, Market Forecast (2016-2026) (US $MN)
133 South America Parkinson'S Disease Treatment Market By Other Therapeutic Classes, Market Forecast (2016-2026) (US $MN)
134 South America Parkinson'S Disease Treatment Market By Amantadine and Anticholinergic, Market Forecast (2016-2026) (US $MN)
135 South America Parkinson'S Disease Treatment Market By Medical Devices, Market Forecast (2016-2026) (US $MN)
136 South America Parkinson'S Disease Treatment Market By Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices, Market Forecast (2016-2026) (US $MN)
137 South America Parkinson'S Disease Treatment Market By Deep Brain Stimulation (DBS) Devices, Market Forecast (2016-2026) (US $MN)
138 South America Parkinson'S Disease Treatment Market By Patient Care Setting, Market Forecast (2016-2026) (US $MN)
139 South America Parkinson'S Disease Treatment Market By Hospitals, Market Forecast (2016-2026) (US $MN)
140 South America Parkinson'S Disease Treatment Market By Clinics, Market Forecast (2016-2026) (US $MN)
141 South America Parkinson'S Disease Treatment Market By Distribution Channel, Market Forecast (2016-2026) (US $MN)
142 South America Parkinson'S Disease Treatment Market By Retail pharmacies, Market Forecast (2016-2026) (US $MN)
143 South America Parkinson'S Disease Treatment Market By Online pharmacies, Market Forecast (2016-2026) (US $MN)
144 South America Parkinson'S Disease Treatment Market By Hospital pharmacies, Market Forecast (2016-2026) (US $MN)
145 South America Parkinson'S Disease Treatment Market By Drug stores, Market Forecast (2016-2026) (US $MN)
146 Middle East & Africa Parkinson'S Disease Treatment Market By Country, Market Forecast (2016-2026) (US $MN)
147 Middle East & Africa Parkinson'S Disease Treatment Market By Therapeutic Class, Market Forecast (2016-2026) (US $MN)
148 Middle East & Africa Parkinson'S Disease Treatment Market By Monoamine oxidase B inhibitors (MAO-B inhibitors), Market Forecast (2016-2026) (US $MN)
149 Middle East & Africa Parkinson'S Disease Treatment Market By Rasagiline, Market Forecast (2016-2026) (US $MN)
150 Middle East & Africa Parkinson'S Disease Treatment Market By Selegiline, Market Forecast (2016-2026) (US $MN)
151 Middle East & Africa Parkinson'S Disease Treatment Market By Dopamine precursors, Market Forecast (2016-2026) (US $MN)
152 Middle East & Africa Parkinson'S Disease Treatment Market By Primidone, Market Forecast (2016-2026) (US $MN)
153 Middle East & Africa Parkinson'S Disease Treatment Market By Phenobarbital, Market Forecast (2016-2026) (US $MN)
154 Middle East & Africa Parkinson'S Disease Treatment Market By Dopamine agonists (non-ergoline), Market Forecast (2016-2026) (US $MN)
155 Middle East & Africa Parkinson'S Disease Treatment Market By Ropinirole, Market Forecast (2016-2026) (US $MN)
156 Middle East & Africa Parkinson'S Disease Treatment Market By Pramipexole, Market Forecast (2016-2026) (US $MN)
157 Middle East & Africa Parkinson'S Disease Treatment Market By Others (apomorphine and rotigotine), Market Forecast (2016-2026) (US $MN)
158 Middle East & Africa Parkinson'S Disease Treatment Market By Catechol-O-methyl transferase (COMT) inhibitors, Market Forecast (2016-2026) (US $MN)
159 Middle East & Africa Parkinson'S Disease Treatment Market By Tolcapone, Market Forecast (2016-2026) (US $MN)
160 Middle East & Africa Parkinson'S Disease Treatment Market By Entacapone, Market Forecast (2016-2026) (US $MN)
161 Middle East & Africa Parkinson'S Disease Treatment Market By Carbidopa/Levodopa, Market Forecast (2016-2026) (US $MN)
162 Middle East & Africa Parkinson'S Disease Treatment Market By Other Therapeutic Classes, Market Forecast (2016-2026) (US $MN)
163 Middle East & Africa Parkinson'S Disease Treatment Market By Amantadine and Anticholinergic, Market Forecast (2016-2026) (US $MN)
164 Middle East & Africa Parkinson'S Disease Treatment Market By Medical Devices, Market Forecast (2016-2026) (US $MN)
165 Middle East & Africa Parkinson'S Disease Treatment Market By Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices, Market Forecast (2016-2026) (US $MN)
166 Middle East & Africa Parkinson'S Disease Treatment Market By Deep Brain Stimulation (DBS) Devices, Market Forecast (2016-2026) (US $MN)
167 Middle East & Africa Parkinson'S Disease Treatment Market By Patient Care Setting, Market Forecast (2016-2026) (US $MN)
168 Middle East & Africa Parkinson'S Disease Treatment Market By Hospitals, Market Forecast (2016-2026) (US $MN)
169 Middle East & Africa Parkinson'S Disease Treatment Market By Clinics, Market Forecast (2016-2026) (US $MN)
170 Middle East & Africa Parkinson'S Disease Treatment Market By Distribution Channel, Market Forecast (2016-2026) (US $MN)
171 Middle East & Africa Parkinson'S Disease Treatment Market By Retail pharmacies, Market Forecast (2016-2026) (US $MN)
172 Middle East & Africa Parkinson'S Disease Treatment Market By Online pharmacies, Market Forecast (2016-2026) (US $MN)
173 Middle East & Africa Parkinson'S Disease Treatment Market By Hospital pharmacies, Market Forecast (2016-2026) (US $MN)
174 Middle East & Africa Parkinson'S Disease Treatment Market By Drug stores, Market Forecast (2016-2026) (US $MN)

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials